Alpha DNA Investment Management’s Westlake Corp WLK Stock Holding History

Alpha DNA Investment Management’s Portfolio WLK Stock Details WLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,535	Closed	-$933K	–	200
2022 Q2	$933K	Buy	+9,535	New	+$1.17M	0.8%	86
2021 Q2	–	Sell	-16	Closed	-$1K	–	662
2021 Q1	$1K	Buy	+16	New	+$1.39K	﹤0.01%	661

Other funds holding WLK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCP

Soroban Capital Partners New York $51.8B AUM 21.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alpha DNA Investment Management's WLK Position: Q3 2022 in Review

Alpha DNA Investment Management sold out of Westlake Corp (WLK) in Q3 2022, closing a stake of 9,535 shares — an estimated $933K sold.

Alpha DNA Investment Management first reported a position in WLK in Q1 2021 and held it in 2 quarters. The position peaked at $933K in Q2 2022. 320 funds tracked by Wall St. Rank hold WLK as of Q3 2022.

Alpha DNA Investment Management reported no remaining Westlake Corp position as of Q3 2022 after selling out during the quarter.
Alpha DNA Investment Management sold 9,535 Westlake Corp shares in Q3 2022, an estimated $933K.
Alpha DNA Investment Management first reported a position in Westlake Corp in Q1 2021 and held it in 2 quarters.
Alpha DNA Investment Management's Westlake Corp position peaked at $933K in Q2 2022.
320 funds tracked by Wall St. Rank held Westlake Corp as of Q3 2022.

Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.